September 19, 2017 Lab Top-10 M&A, Partnerships

Molecular Devices and Cytena Partner to Launch the CloneSelect Single-Cell Printer

Announcing the Single-Cell Printer for documented isolation of cells in clonal cell line development Sunnyvale, Calif. – September 19, 2017 – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This novel system utilizes sophisticated microfluidics-based technology... Read more

September 18, 2017 Lab Top-10 Mass Spectrometry Product Launch

Bruker Launches the timsTOF™ Pro Mass Spectrometer to Enable the Revolutionary PASEF Method for Next-Generation Proteomics

DUBLIN, Sept. 18, 2017 /PRNewswire/ — HUPO2017 — At the 16th Annual World Congress of the Human Proteome Organization (HUPO), Bruker introduces the timsTOF Pro system for PASEF mass spectrometry, using proprietary trapped ion mobility spectrometry (TIMS) technology for higher-speed, higher-sensitivity and robust shotgun proteomics with outstanding single-shot peptide and protein identification performance. The novel timsTOF Pro... Read more

September 13, 2017 Acad, Gov/Utilities Bio/Pharma/CRO Lab Top-10

Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

Assay Detects Genetic Anomalies and Helps Move Inquiries from Cause to Care Faster SANTA CLARA, Calif., September 13, 2017 Agilent Technologies Inc. (NYSE: A) has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization (CGH) assay for diagnostic... Read more

September 13, 2017 Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Completes Subsequent Offering Period of Tender Offer Following Acquisition of Patheon N.V.

Thermo Fisher Scientific Completes Subsequent Offering Period of Tender Offer Following Acquisition of Patheon N.V. WALTHAM, Mass., Sept. 13, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the expiration of the subsequent offering period of its previously announced tender offer to purchase all of the outstanding ordinary shares... Read more